Found: 9
Select item for more details and to access through your institution.
Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making.
- Published in:
- Drug Safety, 2024, v. 47, n. 5, p. 495, doi. 10.1007/s40264-024-01409-5
- By:
- Publication type:
- Article
Correction to: Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Safety of Simultaneous Administration of Bivalent mRNA COVID-19 and Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS).
- Published in:
- Drug Safety, 2024, v. 47, n. 5, p. 487, doi. 10.1007/s40264-024-01406-8
- By:
- Publication type:
- Article
The Role of the European Medicines Agency in the Safety Monitoring of COVID-19 Vaccines and Future Directions in Enhancing Vaccine Safety Globally.
- Published in:
- Drug Safety, 2024, v. 47, n. 5, p. 405, doi. 10.1007/s40264-024-01405-9
- By:
- Publication type:
- Article
A Comparison of Signals of Designated Medical Events and Non-designated Medical Events: Results from a Scoping Review.
- Published in:
- Drug Safety, 2024, v. 47, n. 5, p. 475, doi. 10.1007/s40264-024-01403-x
- By:
- Publication type:
- Article
Risk of Systemic Inflammatory Response Syndrome Following Preoperative Glucocorticoids Administration in Patients After Percutaneous Nephrolithotomy: A Retrospective Cohort Study.
- Published in:
- Drug Safety, 2024, v. 47, n. 5, p. 465, doi. 10.1007/s40264-024-01402-y
- By:
- Publication type:
- Article
In Utero Exposure to Antibiotics and Risk of Serious Infections in the First Year of Life.
- Published in:
- Drug Safety, 2024, v. 47, n. 5, p. 453, doi. 10.1007/s40264-024-01401-z
- By:
- Publication type:
- Article
Tacrolimus-Induced Neurotoxicity After Transplant: A Literature Review.
- Published in:
- Drug Safety, 2024, v. 47, n. 5, p. 419, doi. 10.1007/s40264-024-01398-5
- By:
- Publication type:
- Article
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.
- Published in:
- Drug Safety, 2024, v. 47, n. 5, p. 439, doi. 10.1007/s40264-023-01392-3
- By:
- Publication type:
- Article